MEDP
Medpace Holdings, Inc. · NASDAQ
- Sector Commercial Services
- Industry Miscellaneous Commercial Services
- Website medpace.com
- Employees(FY) 5800
- ISIN US58506Q1094
Performance
-2.92%
1W
+7.09%
1M
-8.64%
3M
-16.31%
6M
+10.03%
YTD
+11.26%
1Y
Profile
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Technical Analysis of MEDP 2024-12-20
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-12-17 19:00
MEDP: Raising target price to $366.00(Argus Research)
- 2024-12-10 19:00
MEDP: Raising target price to $359.00(Argus Research)
- 2024-12-03 19:00
MEDP: Raising target price to $356.00(Argus Research)
- 2024-11-26 19:00
MEDP: Raising target price to $352.00(Argus Research)
- 2024-11-21 18:52
Analyst Report: Medpace Holdings, Inc.(Morningstar Research)
- 2024-11-15 18:47
Analyst Report: Medpace Holdings, Inc.(Morningstar Research)
- 2024-11-12 19:00
MEDP: Raising target price to $379.00(Argus Research)
- 2024-11-07 06:20
When Should You Buy Medpace Holdings, Inc. (NASDAQ:MEDP)?(Simply Wall St.)
- 2024-11-06 18:36
Analyst Report: Medpace Holdings, Inc.(Morningstar Research)
- 2024-11-05 19:00
MEDP: Lowering target price to $345.00(Argus Research)
- 2024-11-04 10:12
What Makes Medpace Holdings (MEDP) a Good Holding?(Insider Monkey)
- 2024-11-01 07:33
- 2024-10-29 09:00
- 2024-10-23 05:54
- 2024-10-23 03:56
Q3 2024 Medpace Holdings Inc Earnings Call(Thomson Reuters StreetEvents)
- 2024-10-22 17:42
Analyst Report: Medpace Holdings, Inc.(Morningstar Research)
- 2024-10-22 16:04
How Medpace Just Blew Up Expectations For Double-Digit Sales Growth In 2025(Investor's Business Daily)
- 2024-10-22 10:09
Medpace Stock Drop. Biotech’s Doldrums Are to Blame.(Barrons.com)
- 2024-10-21 16:25
Medpace: Q3 Earnings Snapshot(Associated Press Finance)
- 2024-10-21 16:15
Medpace Holdings, Inc. Reports Third Quarter 2024 Results(Business Wire)
- 2024-10-21 04:15
- 2024-10-17 14:18
Do Medpace Holdings' (NASDAQ:MEDP) Earnings Warrant Your Attention?(Simply Wall St.)
- 2024-10-16 10:44
LVS Advisory Increased its Investment in Medpace (MEDP) in Q3(Insider Monkey)
- 2024-10-15 23:23
- 2024-10-14 09:46
- 2024-10-10 07:42
Here’s Why Medpace (MEDP) Detracted in Q3(Insider Monkey)
- 2024-10-10 01:56
- 2024-10-08 20:00
MEDP: Raising target price to $355.00(Argus Research)
- 2024-10-08 09:00
- 2024-09-30 09:00
Page 1 of 10
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.